BEXTITUDE Trademark
Trademark Overview
On Wednesday, November 10, 2004, a trademark application was filed for BEXTITUDE with the United States Patent and Trademark Office. The USPTO has given the BEXTITUDE trademark a serial number of 78514586. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, July 25, 2006. This trademark is owned by Bristol-Myers Squibb Company. The BEXTITUDE trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants; diagnostic pharmaceutical preparations used to increase heart rate and contrast imaging agents
General Information
| Serial Number | 78514586 |
| Word Mark | BEXTITUDE |
| Filing Date | Wednesday, November 10, 2004 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Tuesday, July 25, 2006 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 1, 2005 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants; diagnostic pharmaceutical preparations used to increase heart rate and contrast imaging agents |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 16, 2004 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10154 |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10154 |
Trademark Events
| Event Date | Event Description |
| Wednesday, September 27, 2006 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Wednesday, September 27, 2006 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, January 24, 2006 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, November 1, 2005 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 12, 2005 | NOTICE OF PUBLICATION |
| Wednesday, September 14, 2005 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, September 9, 2005 | ASSIGNED TO LIE |
| Tuesday, September 6, 2005 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 23, 2005 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 18, 2005 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 18, 2005 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, April 29, 2005 | PRIORITY ACTION MAILED |
| Friday, April 29, 2005 | PRIORITY ACTION WRITTEN |
| Thursday, April 28, 2005 | ASSIGNED TO EXAMINER |
| Tuesday, November 16, 2004 | NEW APPLICATION ENTERED IN TRAM |
